The Lancet

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial

aDepartment of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA bDepartment of Obstetrics, Gynecology, and Women's Health, University of ...
Science Daily

Flea and tick treatments for dogs and cats may be harming wildlife

Flea and tick medications trusted by pet owners worldwide may have an unexpected environmental cost. Scientists found that active ingredients from isoxazoline treatments pass into pet feces, exposing ...
Psychology Today

Could Glial Cells Be the Key to New Schizophrenia Treatments?

Source: Bioscience Image Library by Fayette Reynolds/Unsplash Anyone living with schizophrenia understands the true limitations of current treatment options. Antipsychotics remain the single leading ...
MarketWatch

Boehringer Ingelheim Gets FDA Emergency Use Authorization for Screwworm Treatments

The Food and Drug Administration granted Boehringer Ingelheim emergency use authorizations for its treatments of New World screwworm in dogs and cats. New World screwworm is a parasitic fly that lays ...